Looks like you clickedhttps://cllsociety.org/2020/06/asco-2020-top-12-11-clinical-activity-of-cirmtuzumab-an-anti-ror1-antibody-in-combination-with-ibrutinib-interim-results-of-a-phase-ib-ii-study-in-mantle-cell-lymphoma-mcl-or-chronic-l/?utm_source=June+30%2C+2020&utm_campaign=June+30%2C+2020+Alert&utm_medium=email
If you do not want to visit that page, you can close this browser tab.
